CSS
ANVS icon

Cubist Systematic Strategies’s Annovis Bio ANVS Stock Holding History

Cubist Systematic Strategies’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-51,347
Closed -$258K – 2826
2024
Q4 		$258K Buy
+51,347
New +$372K ﹤0.01% 2466
2022
Q1 		– Sell
-11,743
Closed -$206K – 3538
2021
Q4 		$206K Buy
+11,743
New +$303K ﹤0.01% 3015
2021
Q3 		– Sell
-4,508
Closed -$386K – 2947
2021
Q2 		$386K Buy
+4,508
New +$208K ﹤0.01% 2174

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return

Cubist Systematic Strategies's ANVS Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Annovis Bio (ANVS) in Q1 2025, closing a stake of 51,347 shares — an estimated $258K sold.

Cubist Systematic Strategies first reported a position in ANVS in Q2 2021 and held it in 3 quarters. The position peaked at $386K in Q2 2021. 44 funds tracked by Wall St. Rank hold ANVS as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Annovis Bio position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 51,347 Annovis Bio shares in Q1 2025, an estimated $258K.
  • Cubist Systematic Strategies first reported a position in Annovis Bio in Q2 2021 and held it in 3 quarters.
  • Cubist Systematic Strategies's Annovis Bio position peaked at $386K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.